Literature DB >> 14629797

Appropriateness of test use in pathology: a new era or reinventing the wheel?

W S A Smellie1.   

Abstract

Pathology has struggled to define and implement changes to improve requesting practices, yet, with the increasing transfer of care from secondary to primary care, our workloads are increasing out of proportion to health care activity. Conversely, some tests appear to be considerably under-used by some general practitioners. Aspects of service reconfiguration such as rationalization of low-volume testing and joint equipment and reagent procurement may release some savings, although any such financial benefits are likely to be quickly nullified by the continued rise in activity and do not contribute to quality of test use. With very large differences between general practices in their use of pathology tests, this review looks at methods for changing pathology requesting activity and calls for involvement from professional organizations to support such initiatives.

Mesh:

Year:  2003        PMID: 14629797     DOI: 10.1258/000456303770367180

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

1.  Methodology for constructing guidance.

Authors:  W S A Smellie; D I Finnigan; D Wilson; D Freedman; C A M McNulty; G Clark
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  Regional variations in test requiring patterns of general practitioners in Spain.

Authors:  María Salinas; Maite López-Garrigós; Julián Díaz; Mario Ortuño; Martin Yago; Begoña Laíz; Arturo Carratala; Virtudes Chinchilla; Goizane Marcaida; Enrique Rodriguez-Borja; Angel Esteban; Marcos Guaita; Cristina Aguado; Miguel A Lorente; Emilio Flores; Joaquín Uris
Journal:  Ups J Med Sci       Date:  2011-11       Impact factor: 2.384

3.  Larger differences in utilization of rarely requested tests in primary care in Spain.

Authors:  Maria Salinas; Maite López-Garrigós; Emilio Flores; Joaquín Uris; Carlos Leiva-Salinas
Journal:  Biochem Med (Zagreb)       Date:  2015-10-15       Impact factor: 2.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.